Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601-Reference-Cited by-同舟云学术

Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601

Published:2013-07 Issue:1 Volume:81 Page:91-96
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Sugawara Shunichi,Maemondo Makoto,Tachihara Motoko,Inoue Akira,Ishimoto Osamu,Sakakibara Tomohiro,Usui Kazuhiro,Watanabe Hiroshi,Matsubara Nobumichi,Watanabe Kana,Kanazawa Kenya,Ishida Takashi,Saijo Yasuo,Nukiwa Toshihiro

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Staging of non-small cell lung cancer: consensus, controversies and challenges;van Meerbeeck;Lung Cancer,2001

3. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer;Dillman;N Engl J Med,1990

4. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer;Sause;Chest,2000

5. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

2. Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society;Haigan;2023-06-20

3. A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer;BMC Cancer;2022-06-20

4. Creation of an Integrated Clinical Trial Database and Data Sharing for Conducting New Research by the Japan Lung Cancer Society;JTO Clinical and Research Reports;2022-05

5. Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data;BMC Pulmonary Medicine;2022-01-09